Literature DB >> 24891473

Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.

Philipp Spitzer1, Zacharias Kohl2, Philipp Gölitz3, Roland Coras4, Ingmar Blümcke4, Wolfgang Brück5, Arnd Dörfler3, Christian Maihöfner6.   

Abstract

Hereditary diffuse leucoencephalopathy with spheroids (HDLS) is a rare autosomal dominantly inherited disease with unknown pathophysiology. Diagnosis of neurodegenerative diseases is increasingly based on biomarkers. Although lumbar puncture is routinely performed during the diagnostic workup of HDLS, reports on alterations of neurodegeneration-specific biochemical markers have not been documented so far. We report a 35-year-old woman with clinical, radiological and neuropathological signs of HDLS. She suffered from a rapidly progressive frontal lobe syndrome. Brain MRI revealed diffuse leucoencephalopathy with predominant involvement of the periventricular white matter and corpus callosum. Although she was severely impaired and leucoencephalopathy was prominent, only cerebrospinal fluid total-τ was moderately elevated. Other markers of neuronal (NSE) and astrocytic (S100B) damage were within normal range. Therefore, biochemical markers of central nervous system damage are not helpful in the diagnosis of HDLS. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24891473      PMCID: PMC4054112          DOI: 10.1136/bcr-2012-008510

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study.

Authors:  Farrah J Mateen; B Mark Keegan; Karl Krecke; Joseph E Parisi; Max R Trenerry; Sean J Pittock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-02-22       Impact factor: 10.154

Review 2.  Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.

Authors:  Argonde C van Harten; Maartje I Kester; Pieter-Jelle Visser; Marinus A Blankenstein; Yolande A L Pijnenburg; Wiesje M van der Flier; Philip Scheltens
Journal:  Clin Chem Lab Med       Date:  2011-02-23       Impact factor: 3.694

3.  CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts.

Authors:  J Paloneva ; T Autti; R Raininko; J Partanen; O Salonen; M Puranen; P Hakola; M Haltia
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

Review 4.  S100B protein in neurodegenerative disorders.

Authors:  Johann Steiner; Bernhard Bogerts; Matthias L Schroeter; Hans-Gert Bernstein
Journal:  Clin Chem Lab Med       Date:  2011-02-09       Impact factor: 3.694

5.  Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS.

Authors:  B M Keegan; C Giannini; J E Parisi; C F Lucchinetti; B F Boeve; K A Josephs
Journal:  Neurology       Date:  2008-02-20       Impact factor: 9.910

Review 6.  Rapid onset frontal leukodystrophy with decreased diffusion coefficient and neuroaxonal spheroids.

Authors:  Elisabeth Maillart; Audrey Rousseau; Damien Galanaud; Françoise Gray; Marc Polivka; Pierre Labauge; Jean-Jacques Hauw; Olivier Lyon-Caen; Olivier Gout; Frédéric Sedel
Journal:  J Neurol       Date:  2009-05-21       Impact factor: 4.849

Review 7.  Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?

Authors:  C Wider; J A Van Gerpen; S DeArmond; E A Shuster; D W Dickson; Z K Wszolek
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

8.  A comparative morphologic analysis of adult onset leukodystrophy with neuroaxonal spheroids and pigmented glia--a role for oxidative damage.

Authors:  Zarina S Ali; J Patrick Van Der Voorn; James M Powers
Journal:  J Neuropathol Exp Neurol       Date:  2007-07       Impact factor: 3.685

9.  Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred.

Authors:  Yasuhiko Baba; Bernardino Ghetti; Matthew C Baker; Ryan J Uitti; Michael L Hutton; Keiji Yamaguchi; Thomas Bird; Wenlang Lin; Michael W DeLucia; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Acta Neuropathol       Date:  2006-03-08       Impact factor: 17.088

Review 10.  Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.

Authors:  K J B Lamers; P Vos; M M Verbeek; F Rosmalen; W J A van Geel; B G M van Engelen
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.